August 1, 2025Drug Design Development and TherapyOpen Access

Efficacy and Safety of Guben Kechuan Granules in the Treatment of Chronic Bronchitis: A Multi-Center and Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Guben Kechuan Granules significantly reduced the time to first acute exacerbation of chronic bronchitis and improved symptom scores for cough, expectoration, and wheezing.
In the experimental group, patients experienced notable enhancements in mobility, self-care, and overall health status after 24 weeks of treatment, with statistical significance.
This multicenter, randomized controlled trial enrolled 300 patients across three groups over a treatment period of 24 weeks, including a 24-week follow-up.
Despite benefits, lung function parameters showed no significant changes after 24 weeks; no serious adverse events were reported during the follow-up.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized controlled trial demonstrates Guben Kechuan Granules improve symptoms and reduce AECB in chronic bronchitis patients, suggesting a valuable TCM approach.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68af2690cf1dd9ea359e1fc9 https://doi.org/10.2147/dddt.s528815

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial demonstrates Guben Kechuan Granules improve symptoms and reduce AECB in chronic bronchitis patients, suggesting a valuable TCM approach.

Efficacy and Safety of Guben Kechuan Granules in the Treatment of Chronic Bronchitis: A Multi-Center and Randomized Controlled Trial

Key Points

Discussion

Implication

Cite This Study

Efficacy and Safety of Guben Kechuan Granules in the Treatment of Chronic Bronchitis: A Multi-Center and Randomized Controlled Trial

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider